Liver Disease Diagnostics Market Size, Share, By Diagnostic Technique (Imaging [Electrography, Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scanner, and Others), Blood Test [(Fragment Omics, Liver Function Test, Antibody Test, and Others), Genetic Test], Disease Type (Hepatitis, Fatty Liver Disease, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Alcoholic Fatty Liver Disease, and Others), End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Abbott
• Boston Scientific Corporation
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd 
• HORIBA
• Perspectum
• FUJIFILM Corporation
• Laboratory Corporation of America Holdings
• Agilus Diagnostics
• Siemens
• Echosens
• Cosara
• Owlstone Medical Ltd
• BIOMÉRIEUX
• Bio-Rad Laboratories, Inc

Recent News:

• Apollo Hospitals, Chennai launched the Fatty Liver Clinic at the liver disease and transplantation institute in April 2024, with cutting-edge diagnostic tools and new pharmacological treatment. India’s growing rated of obesity, diabetes and unhealthy lifestyles contribute to fatty liver diseases such as liver cirrhosis, and liver failure. Thus, Apollo Hospitals, launched FibroScan Expert 630 diagnostic tool, to revolutionize liver care and tackle non-alcoholic fatty liver disease. This advanced equipment, enables spleen stiffness measurement, ultrasound guidance system, and precise risk stratification for advanced chronic liver disease patients to optimized patient care.